EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 170 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.73 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,248,000 | -50.0% | 18,000 | -45.5% | 0.08% | -62.9% |
| Q2 2018 | $2,497,000 | +43.6% | 33,000 | 0.0% | 0.21% | +23.8% |
| Q1 2018 | $1,739,000 | -1.4% | 33,000 | 0.0% | 0.17% | -6.5% |
| Q4 2017 | $1,763,000 | -63.8% | 33,000 | -59.5% | 0.18% | -63.9% |
| Q3 2017 | $4,864,000 | -53.3% | 81,550 | -38.2% | 0.51% | -58.7% |
| Q2 2017 | $10,413,000 | +85.4% | 131,990 | +95.0% | 1.23% | +64.6% |
| Q1 2017 | $5,615,000 | +73.9% | 67,700 | +66.3% | 0.75% | +13.2% |
| Q4 2016 | $3,229,000 | +59.1% | 40,700 | +40.3% | 0.66% | +80.1% |
| Q3 2016 | $2,030,000 | – | 29,000 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 475,755 | $25,068,000 | 24.71% |
| Hudson Executive Capital LP | 971,000 | $51,162,000 | 15.09% |
| Park West Asset Management LLC | 1,051,274 | $55,392,000 | 2.47% |
| U S GLOBAL INVESTORS INC | 19,200 | $1,012,000 | 0.62% |
| Capital Impact Advisors, LLC | 26,317 | $1,387,000 | 0.57% |
| CLARK ESTATES INC/NY | 56,278 | $2,965,000 | 0.47% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 873,131 | $46,005,000 | 0.41% |
| ProQuest Associates IV LLC | 6,777 | $357,000 | 0.41% |
| Granite Investment Partners, LLC | 114,207 | $6,017,000 | 0.40% |
| GLOBEFLEX CAPITAL L P | 30,900 | $1,628,000 | 0.34% |